References
- Brunetti-Pierri N, Scaglia F. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol Genet Metab. 2008;94(4):391–396. DOI: 10.1016/j.ymgme.2008.04.012
- Hofer D, Paul K, Fantur K, et al. GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase. Hum Mutat. 2009;30(8):1214–1221. DOI: 10.1002/humu.21031
- Kaiyrzhanov R, Guliyeva U, Gulieva S, et al. GM1-Gangliosidosis Type III Associated Parkinsonism. Mov Disord Clin Pract. 2021;8(Suppl 1):S21-S23. DOI: 10.1002/mdc3.13289
- Baizabal-Carvallo JF, Jankovic J. Distinguishing features of psychogenic (functional) versus organic hemifacial spasm. J Neurol. 2017;264(2):359–363. DOI: 10.1007/s00415-016-8356-0
- Hajirnis O, Udwadia-Hegde A. Chronic GM1 Gangliosidosis with Characteristic “Wish Bone Sign” on Brain MRI. Another Type of Neurodegeneration with Brain Iron Accumulation? Mov Disord Clin Pract. 2015;2(3):323–325. DOI: 10.1002/mdc3.12197
- Goldman JE, Katz D, Rapin I, Purpura DP, Suzuki K. Chronic GM1 gangliosidosis presenting as dystonia: I. Clinical and pathological features. Ann Neurol. 1981;9(5):465–475. DOI: 10.1002/ana.410090509
- Muthane U, Chickabasaviah Y, Kaneski C, et al. Clinical features of adult GM1 gangliosidosis: report of three Indian patients and review of 40 cases. Mov Disord. 2004;19(11):1334–1341. DOI: 10.1002/mds.20193
- Malik P, Muthusamy K, C M, Danda S, Sudhakar SV. Teaching NeuroImages: Wishbone pattern of iron accumulation: A characteristic imaging sign in GM1 gangliosidosis. Neurology. 2019;92(18):e2176–e2177. DOI: 10.1212/WNL.0000000000007406
- Prasad S, Sahoo LK, Saini J, Pal PK. Wishbone pattern of iron accumulation: A pathognomonic sign of type III GM1 gangliosidosis. Annals of Movement Disorders. 2019;2(3).
https://journals.lww.com/aomd/fulltext/2019/02030/wishbone_pattern_of_iron_accumulation__a.9.aspx - Roze E, Paschke E, Lopez N, et al. Dystonia and parkinsonism in GM1 type 3 gangliosidosis. Movement Disorders. 2005;20(10):1366–1369. DOI: 10.1002/mds.20593
- Maciel ROH, Pedroso JL, Barsottini OGP. Facial grimacing as a clue for the diagnosis of GM1 type 3 gangliosidosis. Arq Neuropsiquiatr. 2011;69(2B):406–407. DOI: 10.1590/S0004-282X2011000300028
- De Grandis E, Di Rocco M, Pessagno A, Veneselli E, Rossi A. MR imaging findings in 2 cases of late infantile GM1 gangliosidosis. AJNR Am J Neuroradiol. 2009;30(7):1325–1327. DOI: 10.3174/ajnr.A1508
- Yoshida K, Oshima A, Sakuraba H, et al. GM1 gangliosidosis in adults: clinical and molecular analysis of 16 Japanese patients. Ann Neurol. 1992;31(3):328–332. DOI: 10.1002/ana.410310316
- Laur D, Pichard S, Bekri S, et al. Natural history of GM1 gangliosidosis-Retrospective cohort study of 61 French patients from 1998 to 2019. J Inherit Metab Dis. 2023;46(5):972–981. DOI: 10.1002/jimd.12646
- Rha AK, Maguire AS, Martin DR. GM1 Gangliosidosis: Mechanisms and Management. Appl Clin Genet. 2021;14:209–233. DOI: 10.2147/TACG.S206076
- Regier DS, Tifft CJ, Rothermel CE.
GLB1-Related Disorders . In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews®. University of Washington, Seattle; 1993. Accessed January 7, 2026.http://www.ncbi.nlm.nih.gov/books/NBK164500/ - Nicoli ER, Annunziata I, d’Azzo A, Platt FM, Tifft CJ, Stepien KM. GM1 Gangliosidosis-A Mini-Review. Front Genet. 2021;12:
734878 . DOI: 10.3389/fgene.2021.734878 - Caciotti A, Garman SC, Rivera-Colón Y, et al. GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings. Biochim Biophys Acta. 2011;1812(7):782–790. DOI: 10.1016/j.bbadis.2011.03.018
- Caciotti A, Donati MA, Bardelli T, et al. Primary and secondary elastin-binding protein defect leads to impaired elastogenesis in fibroblasts from GM1-gangliosidosis patients. Am J Pathol. 2005;167(6):1689–1698. DOI: 10.1016/S0002-9440(10)61251-5
- Hofer D, Paul K, Fantur K, et al. Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations. Clin Genet. 2010;78(3):236–246. DOI: 10.1111/j.1399-0004.2010.01379.x
- Kumar KR, Wali GM, Kamate M, et al. Defining the genetic basis of early onset hereditary spastic paraplegia using whole genome sequencing. Neurogenetics. 2016;17(4):265–270. DOI: 10.1007/s10048-016-0495-z
- Bidchol AM, Dalal A, Trivedi R, et al. Recurrent and novel GLB1 mutations in India. Gene. 2015;567(2):173–181. DOI: 10.1016/j.gene.2015.04.078
- Caciotti A, Donati MA, d’Azzo A, et al. The potential action of galactose as a “chemical chaperone”: increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient. Eur J Paediatr Neurol. 2009;13(2):160–164. DOI: 10.1016/j.ejpn.2008.03.004